发明名称 AMINES
摘要 H-399/405 CA AMINES The invention concerns compounds having formula: (Ia) or a salt thereof, wherein E represents hydrogen, lower alkyl or a group Ar1-A1-; Ar and Ar1 are the same or different aryl groups (including heteroaryl) which are optionally substituted, eg by one or more substituents commonly used in pharmaceutical chemistry; A and A1 are the same or different alkylene groups having one or two carbon atoms linking Ar or Ar1 to N and optionally substituted by lower alkyl and/or optionally substituted aryl, B is an alkylene group of 3 or 4 carbon atoms, which may be substituted by lower alkyl; D1 represents halogen, CH3, CR1R2NH2, SO3H or SO2NR6R7 where R1 and R2 are independently hydrogen or lower alkyl and R6 and R7 are each hydrogen, lower alkyl or aralkyl of 7 to 12 carbon atoms or R6 and R7 togehter with the nitrogen atom to which they are attached represent a 5 or 6 membered ring, which compounds are useful, for treating depression or cerebral insufficiency or dementias in animals.
申请公布号 CA2017966(A1) 申请公布日期 1990.12.02
申请号 CA19902017966 申请日期 1990.05.31
申请人 WYETH, JOHN AND BROTHER LIMITED 发明人 WHITE, JOHN F.;MINCHIN, MICHAEL C. W.;ENNIS, CHRISTINE
分类号 A61K31/165;A61K31/135;A61K31/17;A61K31/255;A61K31/34;A61K31/341;A61K31/343;A61K31/38;A61K31/381;A61K31/44;A61K31/47;A61P25/24;A61P25/26;A61P25/28;C07C211/27;C07C211/28;C07C211/29;C07C211/30;C07C215/50;C07C217/58;C07C255/58;C07C309/14;C07C335/32;C07D213/38;C07D215/12;C07D295/22;C07D307/52;C07D307/78;C07D333/20;C07D521/00;(IPC1-7):C07C211/26;A61K31/185;A61K31/33;C07C211/49;C07C215/46;C07C217/54;C07C309/24;C07D209/04 主分类号 A61K31/165
代理机构 代理人
主权项
地址